116 related articles for article (PubMed ID: 26377577)
1. Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Jiang B; Zhang X; Di D; Luo G; Shi Y; Zhang J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2015 Sep; 14():110. PubMed ID: 26377577
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro.
Zhang X; Jiang B; Luo G; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2007 Jul; 1771(7):879-82. PubMed ID: 17556016
[TBL] [Abstract][Full Text] [Related]
3. Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.
Luo G; Feng Y; Zhang J; Mu Q; Shi Y; Qin L; Zheng L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Int J Med Sci; 2014; 11(10):1015-21. PubMed ID: 25136257
[TBL] [Abstract][Full Text] [Related]
4. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats.
Zheng L; Feng Y; Shi Y; Zhang J; Mu Q; Qin L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Luo G; Xu N
PLoS One; 2014; 9(8):e105681. PubMed ID: 25144649
[TBL] [Abstract][Full Text] [Related]
5. TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells.
Zhu C; Di D; Zhang X; Luo G; Wang Z; Wei J; Shi Y; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Nov; 10():199. PubMed ID: 22054074
[TBL] [Abstract][Full Text] [Related]
6. Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells.
Luo G; Shi Y; Zhang J; Mu Q; Qin L; Zheng L; Feng Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2014 Feb; 445(1):203-7. PubMed ID: 24508264
[TBL] [Abstract][Full Text] [Related]
7. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
Wei J; Shi Y; Zhang X; Feng Y; Luo G; Zhang J; Mu Q; Tang Y; Yu Y; Pan L; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
[TBL] [Abstract][Full Text] [Related]
8. TGF-β Down-regulates Apolipoprotein M Expression through the TAK-1-JNK-c-Jun Pathway in HepG2 Cells.
Ren K; Mo ZC; Liu X; Tang ZL; Jiang Y; Peng XS; Zhang QH; Shi JF; Yi GH
Lipids; 2017 Feb; 52(2):109-117. PubMed ID: 28039587
[TBL] [Abstract][Full Text] [Related]
9. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
Luo G; Hurtig M; Zhang X; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2005 May; 1734(2):198-202. PubMed ID: 15904876
[TBL] [Abstract][Full Text] [Related]
10. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
11. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein M regulates the orphan nuclear receptor LRH-1 gene expression through binding to its promoter region in HepG2 cells.
Pan Y; Zhou HG; Zhou H; Hu M; Tang LJ
Drug Des Devel Ther; 2015; 9():2375-82. PubMed ID: 25987835
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
14. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
15. 17β-estradiol regulates the expression of apolipoprotein M through estrogen receptor α-specific binding motif in its promoter.
Wei J; Yu Y; Luo GH; Feng YH; Shi YP; Zhang J; Mu QF; Yu MM; Pan LL; Berggren-Söderlund M; Nilsson-Ehle P; Zhang XY; Xu N
Lipids Health Dis; 2017 Mar; 16(1):66. PubMed ID: 28359281
[TBL] [Abstract][Full Text] [Related]
16. [Reduced expression and secretion of apolipoprotein M in fat-fed, streptozotocin-diabetic rats is partially reversed by an artificial ligand of PPARγ].
Qu X; Zhao S; Gao J; Hu M; Dong L; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):796-801. PubMed ID: 22954914
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein M: Research progress, regulation and metabolic functions (Review).
Huang LZ; Gao JL; Pu C; Zhang PH; Wang LZ; Feng G; Zhang Y
Mol Med Rep; 2015 Aug; 12(2):1617-24. PubMed ID: 25901639
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Xu N; Ahrén B; Jiang J; Nilsson-Ehle P
Biochim Biophys Acta; 2006 Feb; 1761(2):256-60. PubMed ID: 16542871
[TBL] [Abstract][Full Text] [Related]
20. Hyperglycemia modulates angiotensinogen gene expression.
Gabriely I; Yang XM; Cases JA; Ma XH; Rossetti L; Barzilai N
Am J Physiol Regul Integr Comp Physiol; 2001 Sep; 281(3):R795-802. PubMed ID: 11506994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]